Results 61 to 70 of about 56,492 (197)
SUMMARY Objective: to assess the impact of cell plasma hemostasis disorders and the level of biomarkers on clinical outcomes and to develop laboratory diagnostic criteria forecast recurrent coronary events in patients with unstable angina.
L. G. Gelis +5 more
doaj +1 more source
Abstract Long COVID has a complex pathology and a heterogeneous symptom profile that impacts quality of life and functional status. Post‐exertional symptom exacerbation (PESE) affects one‐third of people living with long COVID, but the physiological basis of impaired physical function remains poorly understood. Sixty‐eight people (age (mean ± SD): 50 ±
Callum Thomas +19 more
wiley +1 more source
OBJECTIVE: To study the incidence of and variation in myocardial ischemia over 48 hours in patients with unstable angina. METHODS: Thirty-nine patients with unstable angina underwent long-term electrocardiography for 48 hours.
Luiz Antônio Machado César +6 more
doaj +1 more source
Abstract figure legend A sudden decrease in total peripheral resistance (TPR), as observed during vasovagal syncope, leads to a reduction in aortic systolic pressure (AO pressure) and afterload. In healthy individuals, the consequent decrease in left ventricular systolic pressure (LV pressure) lowers stroke work and myocardial energy expenditure.
Martin Dvoulety, Michal Sitina
wiley +1 more source
Serious Mental Illness‐Associated Socio‐Medical Needs and Imprisonment Risk in Reentry Clients
Objective To examine whether the socio‐medical needs and imprisonment risk among transitional care clients with serious mental illness (SMI) differ from other transitional care clients. Methods A retrospective cohort study was conducted of adults who entered the Formerly Incarcerated Transition (FIT) Program from 2018 to 2023 following a period of ...
David L. Rosen +3 more
wiley +1 more source
Effect of the use of Clinical Pathway for Patients with Unstable Angina on Nursing Performance and Patient's Outcomes [PDF]
Zienab Ibrahim
openalex +1 more source
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo +22 more
wiley +1 more source
Personalized, patient‐specific biophysical model enabling mechanistic assessment of right ventricular (RV) function as well as robust differentiation of pulmonary hypertension (PH) subtype from routine clinical measurements of pulmonary arterial pressure and flow.
Christopher G. Lechuga +5 more
wiley +1 more source
Platelets of unstable angina patients as effector cells in terahertz radiation at NO frequency
Aim. To investigate the effects of electromagnetic terahertz waves at NO MSIP (molecular specter of radiation and absorption), 240 Hz, on platelet functional activity Р in natural electromagnetic field, as well as in crossed magnetic and electric fields ...
V. F. Kirichuk +5 more
doaj
Can patients with left main coronary artery disease wait for myocardial revascularization surgery?
OBJECTIVE: To assess the occurrence of cardiac events in patients diagnosed with left main coronary artery disease on diagnostic cardiac catheterization and waiting for myocardial revascularization surgery.
Antônio Sérgio Cordeiro da Rocha +1 more
doaj +1 more source

